close
Tuesday May 07, 2024

Pakistanis pin their hopes on CanSino Biologics’ vaccine

By INP
January 30, 2021

ISLAMABAD: As the world competes fiercely for the early acquisition of the Covid-19 vaccines, Pakistani officials, healthcare workers and common people have pinned their hope on Chinese CanSino Biologics anti-coronavirus.

Health experts say that the CanSino vaccine, with promising results during its clinical trials, would be the best option for Pakistanis, having been tested over the indigenous population of the country.

The CanSino vaccine is not the only Chinese vaccine Pakistanis would benefit from, as China announced last week 500,000 doses of the Sinopharm anti-coronavirus vaccine as a gift to Pakistan.

Pakistan’s National Command and Operation Center (NCOC) announced the launch of phase-III clinical trials in the country for CanSino Vaccine in end-September 2020.